Trials
Search / Trial NCT05656053

Intraoperative Rapid Diagnosis of Glioma Based on Fusion of Magnetic Resonance and Ultrasound Imaging

Launched by MINGGE LLC · Dec 16, 2022

Apply for Trial

Trial Information

Current as of February 05, 2025

Active, not recruiting

Keywords

Gliomas Computer Assisted Decision Making

ClinConnect Summary

BACKGROUND:

The extent of glioma resection is directly related to patient survival, and a combination of multiple imaging and molecular pathology imaging methods has been developed to achieve maximum safe resection. In this study, three types of data, preoperative magnetic resonance imaging, intraoperative ultrasound and molecular genotype, will be collected and combined to build an artificial intelligence imaging model to achieve maximum safe resection and prolong patient's life.

PLAN:

In order to achieve the goal of maximum safe resection, we plan to sequentially implement imaging-base...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • • Age over 18 years old
  • • Tumor in non-functional areas of the cerebral hemisphere.
  • • Preoperative diagnosis of glioma.
  • • Undergo glioma removal surgery.
  • Exclusion Criteria:
  • • Postoperative confirmation of non-glioma.
  • • Magnetic resonance or ultrasound data not available.

Trial Officials

Zhifeng Shi, DM

Study Director

Huashan Hospital

Jinhua Yu, DE

Study Chair

Fudan University

Yinhui Deng, DE

Principal Investigator

Fudan University

About Mingge Llc

Mingge LLC is a dynamic clinical trial sponsor dedicated to advancing innovative therapeutic solutions through rigorous scientific research. With a focus on enhancing patient outcomes, the company specializes in designing and managing clinical trials across various therapeutic areas, leveraging cutting-edge methodologies and technology-driven approaches. Mingge LLC is committed to fostering collaborative partnerships with healthcare professionals, research institutions, and regulatory bodies, ensuring adherence to the highest standards of ethics and compliance. Through its comprehensive expertise and a patient-centered approach, Mingge LLC aims to contribute significantly to the development of safe and effective treatments that address unmet medical needs.

Locations

Shanghai, Shanghai, China

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0

Similar Trials